First Trust Amex Biotech Index Fund (FBT) ETF
FBT ETF Info
| Issuer | First Trust Portfolios |
| Expense Ratio | 0.56% |
| Underlying Index | NYSE Arca Biotechnology Index |
| Asset Class | Equity |
| Sector | Health & Biotech ETFs |
| Assets Under Management (AUM) | 3.34B |
| Net Asset Value (NAV) | $149.28 |
| Options? | Yes |
| Total Holdings | 31 |
FBT Stock Chart More Charts
FBT Price/Volume Stats
| Current price | $149.10 |
| Prev. close | $149.26 |
| Day low | $146.82 |
| Day high | $149.20 |
| 50-day MA | $152.23 |
| 200-day MA | $142.35 |
| 52-week high | $159.85 |
| 52-week low | $117.85 |
| Volume | 146,542 |
| Avg. volume | 144,739 |
| Dividend yield | 0.00001% |
FBT Top Holdings
| Symbol | Company | % of Total |
| ACAD | ACADIA Pharmaceuticals Inc. | 4.47% |
| TECH | Bio-Techne Corporation | 4.1% |
| IQV | IQIVA Holdings Inc. | 3.9% |
| ICPT | Intercept Pharmaceuticals Inc. | 3.83% |
| NBIX | Neurocrine Biosciences Inc. | 3.74% |
| REGN | Regeneron Pharmaceuticals Inc. | 3.63% |
| SGEN | Seattle Genetics Inc. | 3.59% |
| ILMN | Illumina Inc. | 3.59% |
| AMGN | Amgen Inc. | 3.59% |
| XON | Intrexon Corporation | 3.56% |
FBT Returns
| 1-mo | -0.11% |
| 3-mo | -1.05% |
| 6-mo | 10.77% |
| 1-year | 17.61% |
| 3-year | 45.44% |
| 5-year | 132.57% |
| YTD | 19.69% |
| 2017 | 37.07% |
| 2016 | -19.59% |
| 2015 | 10.90% |
| 2014 | 47.54% |
| 2013 | 50.55% |
First Trust Amex Biotech Index Fund (FBT) ETF Bio
The investment objective of the First Trust Amex Biotech Index Fund ETF seeks to measure the performance of a cross section of companies in the biotechnology industry that are primarily involved in the use of biological processes to develop products or provide services.
FBT Dividends
| Ex-Dividend Date | Type | Payout Amount | Change | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||